• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Figure F-100 is titled “Change in SDS for venlafaxine compared with placebo.” The figure displays a forest plot reporting the weighted mean difference in SDS scores for patients treated with venlafaxine versus placebo. The plot depicts greater reductions in SDS scores for patients treated with venlafaxine than placebo (2 trials, weighted mean difference −2.06, 95% CI −3.28 to −0.84, I2=0.0%).

Figure F-100Change in SDS for venlafaxine compared with placebo

Timing of outcome assessment: 24 weeks (Davidson, 2006a), 12 weeks (Davidson, 2006b).

From: Appendix F, Meta-Analysis

Cover of Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD)
Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD) [Internet].
Comparative Effectiveness Reviews, No. 92.
Jonas DE, Cusack K, Forneris CA, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.